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Background: From 1999 to 2010, annual disbursements of development assistance for health for vaccinations
increased from $0.5 billion to $2.0 billion (all financial values USD 2010). In its 2012 Global Vaccine Action Plan
(GVAP), the World Health Assembly recommended establishing a comprehensive vaccination resource tracking
system to better understand the source and recipients of these funds, and ultimately their impact on outcomes.
This systematic review aims to respond to the GVAP recommendation in reviewing and assessing the state of the
data and literature on vaccination resource tracking.
Methods: We scrutinized all relevant vaccination resource tracking systems identified in the literature and by
practitioners in the field. We examined schemes used elsewhere in the health sector and by other sectors.
Informant interviews were also conducted to determine what data exists and how it might be utilized. With this
information, we completed a qualitative assessment of existing approaches to vaccination resources tracking.
Results: Tracking systems provide information about some vaccine-related activity in the majority of low- and
middle-income countries. Data are generally available for the period of 2006–2010. Levels of granularity vary.
Interviewees were concerned about the degree of rigor used to validate the data and the lack of verification. Data
are often presented in tabular form, which may be unwieldy for non-technical audiences.
Conclusions: The schemes currently in place to track the resources available for vaccinations were fairly advanced
relative to other mechanisms in the health sector. Nonetheless, the coverage, validity, and accessibility of
vaccination resource tracking data could be ameliorated. Establishing improved feedback loops and verification
mechanisms that connect country-level administrators and the international organizations that support reporting
efforts would enhance data quality.
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In 2010, more than US $2 billion in development assistance
for health (DAH) was spent on vaccinations in low- and
middle- income countries (all financial values in USD 2010)
[1]. This level of spending is the culmination of ten
years of rapid growth: in 2000, spending amounted to
only approximately US $500 million. This growth corre-
sponds with the creation of the GAVI Alliance (GAVI)
as well as the increased support of development assistance
partners such as the Bill and Melinda Gates Foundation,
the World Health Organization (WHO), and other inter-
national organizations.* Correspondence: ahaak@uw.edu
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article, unless otherwise stated.With this rapid growth in spending in mind, in May
2012 the World Health Assembly recommended the
establishment of a comprehensive vaccination resource
tracking system, as outlined in the Global Vaccine Action
Plan (GVAP) developed by the Decade for Vaccines
Collaboration [2]. This landscape analysis responds to
that recommendation with an assessment of the strengths
and weaknesses of the different tracking systems currently
in place. Stakeholders had little information about the
validity, accessibility, costs, and coverage of schemes.
Our objective was to identify how disparate schemes
can be synthesized to achieve the goal of effectively and
comprehensively tracking the resources devoted to im-
munizations. Thus, our aim was to answer the question:
How well are vaccination resources being tracked?entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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We conducted a systematic review of the academic lit-
erature, reporting systems, and data sources related to
resource tracking in health, with a focus on vaccina-
tions. The following databases were searched: Google
(years 2000–2010), Google Scholar (years 2000–2010),
and the Global Health Data Exchange (years 2000–2010).
We used the following search terms for the Google and
Google Scholar searches: “vaccine financing”, “immunization
financing”, “immunisation financing”, “vaccine costing”,
“immunization costing”, “immunisation costing”, “vaccine
funding”, “immunization funding”, and “immunisation
funding”. We used the following keywords for a key-
word search on the Global Health Data Exchange
(http://ghdx.healthmetricsandevaluation.org/keywords):
“government health expenditures”, “government health
budget”, and “financial assistance for health”.
The searches across the three databases yielded 21,896,934
records. An additional 46 sources were identified as po-
tentially applicable as recommended by interviewees.
Duplicates across the three databases and 23 of the rec-
ommended sources were then removed, leaving 1,349
records. These 1,349 records were screened. A total of
738 were excluded because they pertained exclusively
to a time period outside of 2000 to 2010. The remaining
611 records were assessed for eligibility, of which 544
were excluded because no relevant data on vaccine
expenditure, supplies or services were available. The
remaining 67 data sources were included in the quali-
tative assessment. Figure 1, the review flow diagram,
presents this process.
Tracking mechanisms outside of the health sector
were also reviewed to examine whether innovations
applied in other areas could be adopted for vaccination
resource tracking. In addition to tracking expenditures,
our review also considered methods of tracking the
physical goods and services required for the delivery of
vaccinations. Similar to other development assistance
sectors, funds for vaccinations support a complex supply
and delivery chain. Many aspects of that chain produce
data that can compensate for shortcomings in our under-
standing of the financing mechanisms.
Data sources and literature were considered relevant if
they captured information on the following in low- and
middle-income countries: development assistance for health
for vaccinations, government spending on vaccinations,
non-governmental spending on vaccinations, private sector
expenditure on vaccinations, trade in vaccines and vaccine-
related supplies (syringes, etc.), purchase of vaccines and
vaccine-related supplies, and spending on service delivery
for vaccinations. Studies conducted at the global, national,
and sub-national level were included. Studies in languages
other than English were not considered. However, few
mechanisms that operate globally are not provided inEnglish. Studies and data collection were eligible if they
took place between 2000 and 2010, as the period relevant
to GVAP. When present, however, the full spectrum of
years was assessed. The tracking mechanisms operating
over this period were assumed to be the most up-to-date
and innovative. Data sources and literature were evaluated
one-by-one according to the following criteria: costs, cover-
age, validity and accessibility. The source that best fulfilled
the criteria are discussed in the text, while detailed informa-
tion about all sources evaluated in the qualitative analysis
are included in Additional file 1: Data sources by category.
Conclusions were drawn from the evaluation of the sources
against the criteria.
We conducted informant interviews with experts and
practitioners of resource tracking. An expert group of 12
convened by the Decades of Vaccines Collaboration
provided recommendations for interviews. Interviewees
included representatives from the WHO, the World
Bank, the United Nations Children’s Fund (UNICEF),
the Sabin Institute, and representatives from a number
of ministries of health located in Asia and Latin America.
Interviews were unstructured and open-ended, allowing
interviewees to freely express their views of the coverage,
validity, costs, and accessibility of data. Interviewees
were also asked to recommend other vaccine tracking
mechanisms of interest. Views were provided by experts
fulfilling their roles as staff in international organizations,
non-governmental organizations (NGOs), academia, or
government. These interviews focused predominately
on vaccination resource tracking, but suggestions for
tracking efforts to explore throughout health and in
other development sectors were also provided.
In addition to in-person and phone interviews, a
two-day expert group meeting was convened by the
Decades of Vaccines Collaboration in October 2012.
Authors presented preliminary findings. Experts provided
feedback on the costs, coverage, accessibility, and validity
of the data highlighted.
3. Results
Different tracking systems focus on different geographic
scopes and/or funding agencies, so we segment our re-
view of tracking efforts accordingly. In section 3.1, we
examine the three tracking systems which are global
in scope. In section 3.2, we examine systems and stud-
ies implemented in individual countries. In section 3.3,
we examine the tracking of development assistance for
vaccinations. In section 3.4, we examine methods to
track expenditure based on the service delivery chain.
Finally, in section 3.5, we examine how other tracking
systems operate and may (or may not) apply to vaccin-
ation tracking. The Results section provides an overview
of the data and literature most relevant to resource
tracking Table 1.
Figure 1 Review flow diagram.
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Table 1 Summary of resource tracking assessment
Tracking scheme Criteria Assessment
Joint Reporting Form (JRF) Coverage 2006 to 2012. Highly aggregated. Spending by NGOs and the private sector not available.
Validity Relies on self-reporting. Standardized forms sent to governments on an annual basis.
Reports compared by WHO and UNICEF, with some checks on implausible data.
Accessibility Spreadsheet. Publicly available. No visualizations.
Costs Low but duplication of effort across the cMYPs and APRs in certain years.
Comprehensive Multi-Year Plans (cMYPs) Coverage Only one to two years of baseline data available. 72 low- and middle-income countries
missing. Highly disaggregated. Spending by NGOs and the private sector not available.
Validity Relies on self-reporting. Data provided by governments as part of multiyear planning
processes. Little validation.
Accessibility Spreadsheet. Publicly available. No visualizations.
Costs Low but duplication of effort across the APRs and JRF in certain years.
Annual Progress Reports (APRs) Coverage Only for GAVI-eligible countries. Only updated when GAVI requires. Only covers select
vaccines. Moderate disaggregation.
Validity Relies on self-reporting. Provided by governments as part of applying for further
funding from GAVI. Little validation.
Accessibility Spreadsheet. Publicly available. No visualizations.
Costs Low but duplication of effort across the cMYPs and JRF in certain years.
Sabin Institute’s Sustainable Immunization
Financing Program
Coverage Only covers 18 countries. Government expenditure only. Not an annual, systematized
resource tracking process.
Validity High given detailed, step-by-step tracking.
Accessibility All details not currently available in the public domain.
Costs Time and resource intensive
Ad hoc country studies Coverage Comprehensive data collection exercise at the country level. Not replicable on a yearly
basis on a global scale.
Validity More reliable than most sources given the intensive data collection and analytical exercises
typically involved.
Accessibility In the public domain, generally, but not amassed in one location or systematically reviewed.
Costs Time and resource intensive.
Leach-Kemon et al. BMC Health Services Research 2014, 14:421 Page 4 of 10
http://www.biomedcentral.com/1472-6963/14/4213.1 Comprehensive systems implemented globally
Across countries, there are three main vaccination tracking
mechanisms: the WHO-UNICEF Joint Reporting Form
(JRF), the WHO’s comprehensive Multi-Year Plans
(cMYPs), and GAVI’s Annual Progress Reports (APRs).
All three of these systems track resources in a wide range
of low- and middle-income countries and are publicly
available through the respective organizations’ websites.
Through the JRF, the WHO, and UNICEF aim to
minimize the reporting burden by creating a centralized
and standardized national reporting mechanism. The JRF
dataset provides information on four vaccination spending
components: total expenditure on vaccines, government
expenditure on vaccines, total expenditure on routine
immunizations, and government expenditure on routine
immunizations [3]. The information dates to 2006 and
is currently available through 2012. The coverage of the
data is extensive: more than 90 low- and middle-income
countries have participated in the JRF process. However,
our interviews led us to conclude that national and
international stakeholders are largely unsatisfied withthe process and output. The main issue expressed by
stakeholders is that rigorous, consistent verification of
the data is generally lacking. When data appear highly
implausible, WHO and UNICEF do sometimes reach
out to relevant parties to clarify data points. Beyond
this ad hoc intervention, many stakeholders reported
that little feedback is provided.
The cMYPs, another dataset supported by the WHO,
are not designed to be a tracking system per se but rather
a tool for countries to plan for investments in vaccination
infrastructure and services. The cMYP Immunization
Financing Database contains a combination of actual
and projected cost and financing data [4]. Government
representatives compile the financial information for
baseline years. Forecasts for future resource needs are
derived from the baseline. The advantage of the cMYPs
over any tracking exercise is the granularity of the in-
formation. However, a major drawback is that expend-
iture data are not available beyond the few baseline
years. Additionally, as country-based planning documents,
the cMYPs are not reviewed intensely by any tracking
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a global tracking process due to the varying motivations
for developing this document. These baseline years are
updated sparingly, such that most countries report only
one or, at most, two years of expenditure data. Similar to
the JRF, stakeholders expressed concerns about the
process used to validate the data. The rigor of data collec-
tion and the accuracy of information in the database were
reported as largely unsatisfactory. Furthermore, the granu-
larity of the data necessitates much more time and re-
sources to compile than that necessary for the JRFs. The
high level of detail, however, does make the data more
relevant to analyses that disaggregate spending on services
versus the vaccines themselves.
Another central source of data is GAVI’s APRs [5].
Countries that receive funds from GAVI are required to
submit APRs to the GAVI Secretariat; these reports are
used to determine whether funding should continue or
if any adjustments to the funding scheme are necessary.
The APRs provide information that is similar to, albeit
less detailed than, the cMYPs. The APRs provide infor-
mation on the following categories of expenditure: trad-
itional vaccines, new vaccines, injection supplies, cold chain
equipment, personnel, other operational costs, supplemen-
tal vaccination activities, and total expenditure. One key
shortcoming of the APRs is they do not report on the entir-
ety of spending on vaccinations in each country. They focus
on the vaccines and operations supported by GAVI. APRs
are available for more countries than the cMYPs, but fewer
than the JRF. APRs are required to be submitted to GAVI
as supporting documents when applying for further fund-
ing, and are thus only updated concurrently with the GAVI
funding cycle. Similar to the JRFs and cMYPs, the data have
not been rigorously validated according to informants.
Overall, the cMYPs and APRs cover fewer years and
countries than the JRF, but are more detailed. Informants
suggested that the data validation process for these sources
was weak and suppliers of data receive little feedback.
Furthermore, timing is another key issue. There is a
one-and-a-half-year lag for finalization of the JRF data-
set. APRs are updated annually, but also typically suffer
from a two-year lag. The cMYPs are refreshed only
when a national planning effort takes place, which can
occur as far as 5 to 10 years apart.
3.2 Country-specific systems
A number of vaccination resource tracking efforts have
been conducted at the country level, and these systems
generally reflect the organization of a given country’s health
system. For example, Waters et al. conducted a study
on the coverage and costs of childhood vaccinations in
Cameroon [6]. Capobianco and Naido reviewed health
sector aid financing in Somalia, including the collec-
tion of data on vaccination financing [7]. However, themajority of these exercises appear to be one-off studies
that do not provide comparable information on an an-
nual basis. The exception to this is the Sabin Institute’s
Sustainable Immunization Financing Program which
works in 18 countries across Asia and Africa [8]. With
the help of government officials, program staff have
followed resources step-by-step through the disburse-
ment process: they track the chain of events from when
funding is first allocated, to when ministries of finance
and health plan their budgets, to the point at which
funds are actually disbursed.
National Health Accounts (NHAs) also collect data on
expenditure. Although the 2003 guide for producing
NHAs includes a section on vaccination expenditures,
our review of more than 900 country-years of NHA data
for 120 countries uncovered less than 20 country-years of
reported vaccination spending [9]. If NHA data collection
processes began to systematically produce this information,
these data could be relevant. However, NHAs and similar
subaccounts (National AIDS Spending Assessments and
Maternal and Child Health Subaccounts) are much more
resource intensive than the JRF, cMYPs, and APRs.
3.3 Development assistance for vaccinations
More detailed and standardized data are available from
organizations that provide development assistance to
vaccination programs and the procurement of vaccines.
These include bilateral aid organizations, multilateral or-
ganizations, private foundations, and others. A number
of organizations are dedicated to tracking development
assistance, but unfortunately, vaccination spending has
not been a major focus of these endeavors. A predominant
source of development assistance tracking is the Creditor
Reporting System (CRS) database of the Organization for
Economic Co-operation and Development (OECD) [10].
In the CRS, vaccination projects are not assigned a spe-
cific purpose code and thus cannot be easily identified.
Entities like the International Health Partnership, WHO,
and ONE also use OECD data to track donor contribu-
tions but, again, do not track vaccination financing spe-
cifically [11-13]. Another initiative devoted to tracking
development assistance is AidData, although no disag-
gregation of vaccination program funding is currently
available [14].
Utilizing the CRS, researchers from the London School of
Hygiene and Tropical Medicine (LSHTM) have estimated
the immunization funding provided by development assist-
ance partners to 74 developing countries between 2003 and
2010 as part of the Countdown to 2015 Initiative [15].
The estimates relied on hand coding projects, a resource-
intensive approach prone to subjectivity. At this stage, fur-
ther disaggregating these data by country and producing
annual estimates would require considerable additional
resources. Substantial coverage gaps also exist: Bill and
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GAVI spending prior to 2007 were not included.
Multilateral and bilateral partners, as well as not-for-
profit organizations, are also increasingly transparent about
their spending. However, large gaps in data still prohibit
comprehensive tracking. The most detailed data are pro-
vided by the Pan American Health Organization (PAHO),
which reports the total value of vaccines procured for each
country [16]. UNICEF, in contrast, does not publish infor-
mation on the value of vaccine procurement for specific
countries, but does publish data on total vaccine procure-
ment by antigen and country [17,18]. GAVI reports timely
country disbursement data on its website [19]. Data on
vaccine funding channeled by WHO, the WHO-based
Global Polio Eradication Initiative, the World Bank, and
the Advanced Market Commitment (AMC) are not suffi-
ciently detailed to inform the resource tracking envisioned
in the GVAP [20-23].
One of the largest gaps in this category is vaccine fi-
nancing from NGOs and religious organizations. While
some NGOs publish aggregate numbers on total vaccine
financing, it is very difficult to determine how much
vaccine-specific funding these organizations are spending
in specific countries. A substantial amount of resources
would have to be committed in order to obtain NGO
vaccination expenditure via correspondence.
The DAH database of the Institute for Health Metrics
and Evaluation (IHME) has the potential to be one reliable
source of data [24]. These data are amassed on a yearly
basis from annual reports, government documents, audited
financial statements, tax forms, and data sets from public
and private donors. The development assistance spend-
ing could be drawn out of the current database with the
use of keyword search terms and informed review by
IHME researchers.
Overall, there are quite a few data sources that include
development assistance for vaccinations. However, with
the exception of the LSHTM Countdown to 2015 esti-
mates, none of these schemes currently reports informa-
tion specifically about vaccinations. While this information
can be drawn from several of these publicly available data-
bases (CRS, others), resources and time would be required
to compile and collate this information. Furthermore, all of
these initiatives depend on self-reporting by multilaterals,
bilaterals, and, in some cases, NGOs. While these data are
generally considered reliable, they are also not cross-
validated with country experts. Finally, because develop-
ment assistance covers only a portion of the vaccine
delivery tab, any tracking effort that relied exclusively on
these sources would be providing partial information.
3.4 Service delivery chain
A number of private and public actors support the supply
and service delivery chain associated with vaccinations.Biomedical research firms, wholesalers, distributors, health
facilities, and other entities contribute to vaccinations in
one way or another. Private actors are also important in
low- and middle-income countries. Unfortunately, infor-
mation about these actors’ behavior is relatively sparse.
The most useful data on distribution and procurement is
available from UNICEF [17,18]. It reports detailed data on
the number of vaccines and vaccine supplies procured on
behalf of GAVI for specific countries. However, the data
on total number of doses of vaccines procured by UNICEF
is not available at the country level. Commodity data re-
ported in the AMC Annual Reports provides information
on the total number of vaccine doses purchased by
UNICEF with funds from GAVI and AMC, but these data
are not broken down by country [25]. The GAVI pro-
curement commodity data reported by UNICEF could
be used to supplement these data. PAHO also procures
a large amount of vaccines; this information could po-
tentially be obtained via correspondence but is not gen-
erally available [16].
Many low- and middle-income countries do not produce
vaccines domestically. Therefore, the United Nations
Comtrade and International Trade Center databases
can also be used to track vaccine commodities [26,27].
These databases provide information regarding the
number of antigens and other supplies imported.
In terms of information on service delivery, Service
Provision Assessment (SPA) surveys could provide data
from nationally representative samples of public, private,
and not-for-profit health facilities in low- and middle-
income countries [28]. SPAs collect information on the
provision of vaccination services, the availability and distri-
bution of vaccines by antigen, and cold chain management.
SPAs are currently only available for fourteen countries
(Bangladesh, Egypt, Ghana, Guatemala, Guyana, Haiti,
Kenya, Malawi, Namibia, Rwanda, Senegal, Tanzania,
Uganda, and Zambia) over 1997 – 2013 [29].
Overall, any financial tracking exercise could be viably
augmented by the good information on procurement
and service delivery related to vaccinations. However,
again, comprehensiveness is lacking. Poor information
about service delivery and procurement in low- and
middle-income countries persists, particularly as re-
lated to private sector procurement and service deliv-
ery [30]. Investment in research and development
activities is also a clear gap.
3.5 Other tracking mechanisms
To complement our review of vaccination resource track-
ing, we also conducted an appraisal of tracking mechanisms
in other areas of health as well as outside of health. These
sources were not included in our systematic review and
were only evaluated for comparison purposes. Numerous
approaches for tracking disease-specific financing have
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Much of this information is produced in a manner similar
to the JRF, cMYPs and APRs. However, a few mechanisms
incorporate innovations to systems, feedback mechanisms,
and presentation of data. The World Malaria Report,
for example, improves upon data collected directly from
donors and standard reporting forms with in-country
consultations and household surveys [31]. The Global
Tuberculosis Report stands out for its introduction of
electronic reporting (including built-in, real-time checks)
and thorough follow-up with respondents, including
country visits and regional workshops [32]. The Every
Woman, Every Child Initiative distinguishes its track-
ing of funds with the use of structured interviews and
questionnaires [33].
To ascertain whether lessons could be learned from re-
source tracking in non-health sectors, we also reviewed a
number of those mechanisms. In general, these schemes
face challenges similar to those associated with vaccination
resource tracking. The non-health resource tracking
systems operating at the international level consist
mostly of following the disbursement of the publicly
available financial resources provided by bilateral and
multilateral organizations. The majority of the information
is self-reported by governments [34-37]. On the whole,
most tracking systems rely on project-based data provided
by donors or, in some cases, questionnaires filled out by
recipient country officials [38-53]. The lack of oversight
and accountability involved in the assembly and provision
of much of this data makes for inaccuracy and inconsisten-
cies. There are few systems that employ systematic or data-
based checks. They also do not provide a comprehensive
picture of non-aid spending on the relevant target.
In terms of tracking the availability of development-
assistance related commodities, the sources of data and
methods are more readily available than financial data.
Maps, reports, and databases provided by the Rome-based
agencies and their affiliates are based on household surveys
and trade data in addition to questionnaires sent to gov-
ernments and publicly available data sources [54-56]. The
World Food Programme’s Vulnerability Analysis and
Map draws predominately from household surveys and
employs advanced food security methods to assess
current and projected availability of food [54,57]. The
International Food Aid Information System tracks food aid
flows based on quantity reporting by donor governments,
international organizations, NGOs, recipient countries and
World Food Programme (WFP) field offices [58]. WFP
reports that these data are cross-checked and continu-
ously updated.
4. Discussion
A number of data sources are available to track the funds
allocated to vaccinations. These tracking exercises varyaccording to: coverage, validity, accessibility, and costs.
This section discusses the strengths and weaknesses of
the data according to these criteria. Overall, coverage of
a wide range of countries and years of data are available.
However, the validity and accessibility of these data
sources are low. Costs vary according to the type of
study, but there is clear duplication of efforts across the
globally active data collection exercises.
4.1 Coverage
In assessing the reporting systems currently operating,
we find that the sources cover low- and middle-income
countries well. The number of years provided, however,
is not very broad and the granularity of expenditure data
varies widely across the tracking schemes. The coverage
over years is important because tracking schemes, much
like surveillance, need to be updated on a yearly basis if
they are to be useful. The core vaccination resource track-
ing mechanisms, the JRF, cMYPs, and APRs, provide data
that cover the majority of low- and middle-income
countries. These data are of varying levels of granularity.
The cMYPs are the source with the finest breakdown of
expenditure information, followed by the APRs. The
mechanism with the highest level of aggregation, the JRF,
still collects information important for monitoring vaccin-
ation funding. While the cMYP data are not systematically
produced, JRF and APR data are collected annually. The
Sabin Institute Sustainable Immunization Financing Initia-
tive as well as ad hoc country studies provide comprehen-
sive, detailed information about the resources available,
but are only available for a limited number of countries
and few years.
The information provided by the JRF, cMYPs, and
APRs allows stakeholders to make decisions at the
national level. However, sometimes sub-national differ-
ences in expenditure are more important. In contrast,
the Sabin Institute’s work duly traces the flow of funds
intended for vaccinations across the supply and delivery
chain and as they trickle from the national level down
to more decentralized units.
Culling feedback on the pertinence of different levels
of detail in datasets could strengthen the usefulness of
the information. A key finding of this review is that while
much is known about the financial resources allocated to
vaccinations, not much is known about how these finan-
cial resources translate into the supply and service delivery
components and, ultimately, seroconversion rates and
vaccine effectiveness. The lack of information at the sub-
national level, as well as the limited disaggregation in the
JRF and APRs, makes these data less useful for managers
in the field; these data sources do not provide information
that is timely or targeted enough for managers of the sup-
ply chain, for example, to assess spending for cost savings
or gaps in financial flows. Furthermore, serious gaps exist
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vaccination research and development, procurement, and
service delivery.
4.2 Validity
The validity of tracking mechanisms, in terms of whether
they are a true reflection of reality and thus accurate and
dependable, could also be strengthened. The core resource
tracking systems depend largely on voluntarily provided
data that are not largely validated. This includes the JRF,
cMYPs, APRs, and many other development assistance
tracking mechanism reviewed. Informants communi-
cated that, due to lack of robust support, data managers
have not always been able to conduct data collection
processes in a rigorous manner. Data managers are not
incentivized to provide highly accurate data nor do they
face pressure to improve data if they are of doubtful
quality. The lack of checks on most of the reported data
leaves room for inconsistencies and inaccuracies. The
country studies and Sabin Institute work are likely the
most accurate among the tracking endeavors reviewed
due to the intensive efforts undertaken to comprehen-
sively collect data at the country level. Vaccination re-
source tracking could build on the approaches applied
in producing the Global Tuberculosis Report, where
WHO staff invest substantial effort in reviewing data,
providing feedback to countries on data quality issues,
and promoting tools for in-country validation of results.
This includes employing strict online tracking with
technological checks on data, person-to-person feedback
on implausible data points, and regional workshops or
consultations to improve reporting.
4.3 Accessibility
For non-technical audiences unaccustomed to handling
large amounts of data, the JRF, cMYPs, and APRs do
not provide information that can be readily inter-
preted. Data produced in other tracking schemes has
been presented in a way that is easily understandable
to all stakeholders. Some tracking mechanisms operat-
ing outside of health, such as the Climate Funds Update
and Global Humanitarian Assistance, have generated
immediately interpretable and targeted visualizations
[31,33]. The vaccination resource tracking mechanisms
reviewed do not regularly produce visualization tools,
including maps. Furthermore, not all cMYP and JRF
data are publicly available; publishing all information
collected would improve accessibility.
4.4 Costs
It is important that systematic resource tracking endeavors
are not burdensome to those who provide vaccinations and
do not divert resources away from administering vaccines.
The Sabin Institute’s work and the ad hoc country studiesare generally much more time and resource intensive. The
JRF, cMYPs, and APRs, meanwhile, require fewer resources.
The cMYP, however, poses a substantial cost in countries
with decentralized health systems or with a substantial
number of development assistance partners. One way
to reduce costs would be to streamline the data collec-
tion occurring across the JFR, APRs, and cMYPs and
eliminate duplication.5. Conclusion
This review shows that a number of concerted efforts
track the resources allocated to vaccinations. Relative to
other areas in health, information about these funds and
the services and supplies required for delivery is fairly
advanced. However, there is room for improvement across
all of the criteria.
The coverage, validity, and accessibility of vaccination
resource tracking data could be improved with a number of
changes to the tracking systems currently operating. First,
streamlining data collection processes and eliminating
duplication would reduce the amount of work required
of data managers at the country level. This could allow
data managers to spend more time and resources fo-
cusing on collecting quality data. Once amassed, data-
sets could be improved with technological checks to
flag implausible values as well as feedback and follow-
up by the entities tasked with collecting data globally
(WHO and UNICEF, for example). Coverage could be
improved by enhancing the validity of retrospective
datasets. Using a regression model, reported spending
could be tied to the delivery of goods and services and
coverage rates. With imputation, it may be possible to
fill in missing values. Finally, accessibility could be im-
proved by developing tools to visualize the data in dif-
ferent dimensions which are easily interpretable by a
wide range of stakeholders.
If tracking mechanisms are to be useful, data must be of
high quality and packaged in a relevant, easily understood
manner. Their usefulness and application may, in turn,
reinforce the need for quality data and thereby encourage
rigorous reporting. However, there are clear trade-offs be-
tween the resource requirements (both time and money)
for highly accurate information and the other criteria. The
most reliable data are the most costly to produce.Additional file
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